{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:57:33Z","timestamp":1790521053914,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T00:00:00Z","timestamp":1307491200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00228-011-1067-7","type":"journal-article","created":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T03:38:28Z","timestamp":1307417908000},"page":"1189-1198","source":"Crossref","is-referenced-by-count":21,"title":["Prescribed drugs and violence: a case\/noncase study in the French PharmacoVigilance Database"],"prefix":"10.1007","volume":"67","author":[{"name":"the French Association of Regional PharmacoVigilance Centres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Rouve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleh","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Telmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Franchitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Roug\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryse","family":"Lapeyre-Mestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,8]]},"reference":[{"key":"1067_CR1","unstructured":"World Health Association. World report on violence and health. 2002 http:\/\/www.who.int\/violence_injury_prevention\/violence\/world_report\/en\/summary_en.pdf date of access 23 2 2011"},{"key":"1067_CR2","volume-title":"Violence: a public heath priority","author":"WHO Global Consultation on Violence and Health","year":"1996","unstructured":"WHO Global Consultation on violence and Health (1996) Violence: a public heath priority. World Health Association, Geneva (document WHO\/EHA\/SPI.POA.2)"},{"key":"1067_CR3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00002826-198812000-00001","volume":"11","author":"MH Sheard","year":"1988","unstructured":"Sheard MH (1988) Clinical Pharmacology of aggressive behavior. Clin Neuropharmacol 11:483\u2013492","journal-title":"Clin Neuropharmacol"},{"key":"1067_CR4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.encep.2007.05.005","volume":"34","author":"T Saias","year":"2008","unstructured":"Saias T, Gallarda T (2008) Paradoxical aggressive reactions to benzodiazepine use: a review. Encephale 34:330\u2013336","journal-title":"Encephale"},{"key":"1067_CR5","first-page":"1478","volume":"3","author":"D Healy","year":"2006","unstructured":"Healy D, Herxheimer A, Menkes DB (2006) Antidepressants and violence: problems at the interface of medicine and law. PLoS Med 3:1478\u20131487","journal-title":"PLoS Med"},{"key":"1067_CR6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2125.1997.00652.x","volume":"44","author":"AC Egberts","year":"1997","unstructured":"Egberts AC, Meyboon RH, De Koning FH, Bakker A, Leufkens HG (1997) Non puerperal lactation associated with antidepressant drug use. Br J Clin Pharmacol 44:277\u2013281","journal-title":"Br J Clin Pharmacol"},{"key":"1067_CR7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2125.1997.00615.x","volume":"44","author":"N Moore","year":"1998","unstructured":"Moore N, Kreft-Jais C, Haramburu F, Noblet C, Andrejak M, Ollagnier M, Begaud B (1998) Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case\/noncase study in the French pharmacovigilance system database. Br J Clin Pharmacol 44:513\u2013518","journal-title":"Br J Clin Pharmacol"},{"key":"1067_CR8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00002018-200225060-00010","volume":"25","author":"AC Egberts","year":"2002","unstructured":"Egberts AC, Meyboom RH, van Puijenbroek EP (2002) Use of measures of disproportionality in pharmacovigilance: three Dutch examples. Drug Saf 25:45\u2013458","journal-title":"Drug Saf"},{"key":"1067_CR9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/0895-4356(92)90158-J","volume":"45","author":"BH Stricker","year":"1992","unstructured":"Stricker BH, Tijssen JG (1992) Serum sickness-like reactions to cefaclor. J Clin Epidemiol 45:1177\u20131184","journal-title":"J Clin Epidemiol"},{"key":"1067_CR10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00228-004-0813-5","volume":"60","author":"S Lugardon","year":"2004","unstructured":"Lugardon S, Lapeyre-Mestre M, Montastruc JL (2004) The French Network of PharmacoVigilance Centres. Upper gastrointestinal adverse drug reactions and cyclooxygenase- 2 inhibitors (celecoxib and rofecoxib): a case\/non-case study from the French Pharmacovigilance Database. Eur J Clin Pharmacol 60:673\u2013677","journal-title":"Eur J Clin Pharmacol"},{"key":"1067_CR11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2125.2003.01968.x","volume":"57","author":"AM Wilson","year":"2004","unstructured":"Wilson AM, Thabane L, Holbrook A (2004) Application of data mining data in pharmacovigilance. Br J Clin Pharmacol 57:127\u2013134","journal-title":"Br J Clin Pharmacol"},{"key":"1067_CR12","first-page":"557","volume":"50","author":"N Moore","year":"1995","unstructured":"Moore N, Noblet C, Kreft-Jais C, Lagier G, Ollagnier M, Imbs JL (1995) French PharmacoVigilance Database system: examples of utilization. Therapie 50:557\u2013562","journal-title":"Therapie"},{"key":"1067_CR13","volume-title":"International monitoring of adverse reactions to drugs: adverse reaction terminology","author":"WHO","year":"1992","unstructured":"WHO (1992) International monitoring of adverse reactions to drugs: adverse reaction terminology. WHO collaborating Centre for International Drug Monitoring, Uppsala"},{"key":"1067_CR14","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis and management. Lancet 356:1255\u20131259","journal-title":"Lancet"},{"key":"1067_CR15","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/sim.1157","volume":"21","author":"PG Heijden Van der","year":"2002","unstructured":"Van der Heijden PG, Van Puijenbroek EP, Van Buuren S, Van der Hofstede JX (2002) On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of underreporting on odds ratios. Stat Med 21:2027\u20132044","journal-title":"Stat Med"},{"key":"1067_CR16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1472-8206.2007.00552.x","volume":"22","author":"A Bate","year":"2008","unstructured":"Bate A, Lindquist M, Edwards IR (2008) The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database. Fundam Clin Pharmacol 22:127\u2013140","journal-title":"Fundam Clin Pharmacol"},{"key":"1067_CR17","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.neuint.2007.10.018","volume":"52","author":"S Engelborghs","year":"2008","unstructured":"Engelborghs S, Vloeberghs E, Le Bastard N, Van Buggenhout M, Marien P, Somers N, Nagels G, Pickut BA, de Deyn PP (2008) The dopaminergic neurotransmitter system is associated with aggressiveness and agitation in frontotemporal dementia. Neurochem Int 52:1052\u20131060","journal-title":"Neurochem Int"},{"key":"1067_CR18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tips.2008.01.002","volume":"29","author":"T Pattij","year":"2008","unstructured":"Pattij T, Vanderschuren JMJ (2008) The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 29:192\u2013199","journal-title":"Trends Pharmacol Sci"},{"key":"1067_CR19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.avb.2008.06.003","volume":"13","author":"D Seo","year":"2008","unstructured":"Seo D, Patrick CJ (2008) Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggressiveness and its comorbidity with oter clinical disorders. Aggress Violent Behav 13:383\u2013395","journal-title":"Aggress Violent Behav"},{"key":"1067_CR20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00023210-200923020-00005","volume":"23","author":"SS O\u2019Sullivan","year":"2009","unstructured":"O\u2019Sullivan SS, Evans AH, Lees AJ (2009) Dopamine Dysregulation Syndrome: an overview of its epidemiology, mechanism and management. CNS Drugs 23:157\u2013170","journal-title":"CNS Drugs"},{"key":"1067_CR21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/mds.20288","volume":"20","author":"FR Pezzella","year":"2005","unstructured":"Pezzella FR, Colossimo C, Vanacore N, Di Rezze S, Chianese M, Fabbrini G, Meco G (2005) Prevalence and Clinical Features of Hedonic Homeostatic Dysregulation in Parkinson\u2019s Disease. Mov Disord 20:77\u201380","journal-title":"Mov Disord"},{"key":"1067_CR22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1067\/mjd.2001.117730","volume":"45","author":"DK Wysowski","year":"2001","unstructured":"Wysowski DK, Pits M, Beitz J (2001) An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 45:515\u2013519","journal-title":"J Am Acad Dermatol"},{"key":"1067_CR23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1056\/NEJM200102083440616","volume":"344","author":"DK Wysowski","year":"2001","unstructured":"Wysowski DK, Pits M, Beitz J (2001) Depression and suicide in patients treated with isotretinoin. N Engl J Med 344:460","journal-title":"N Engl J Med"},{"key":"1067_CR24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4088\/JCP.v69n0403","volume":"69","author":"L Azoulay","year":"2008","unstructured":"Azoulay L, Blais L, Koren G, LeLorier J, Berard A (2008) Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry 69:526\u2013532","journal-title":"J Clin Psychiatry"},{"key":"1067_CR25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-4632.2006.02660.x","volume":"45","author":"JE Strahan","year":"2006","unstructured":"Strahan JE, Raimer S (2006) Isotretinoin and the controversy of psychoiatric advers events. Int J Dermatol 45:789\u2013799","journal-title":"Int J Dermatol"},{"key":"1067_CR26","doi-asserted-by":"crossref","first-page":"c5812","DOI":"10.1136\/bmj.c5812","volume":"341","author":"A Sundstrom","year":"2010","unstructured":"Sundstrom A, Alferdsson L, Sjolin-Forsberd G, Gerden B, Bergman U, Jokinen J (2010) Association of suicide attempt with acne and treatment with isotretinoin: retrospective Swedish cohort study. Br Med J 341:c5812","journal-title":"Br Med J"},{"key":"1067_CR27","unstructured":"European Medecine Agency. Rimonabant: withdrawal of the marketing authorization in the European Union. http:\/\/www.ema.europa.eu\/humandocs\/PDFs\/EPAR\/acomplia\/3945709en.pdf"},{"key":"1067_CR28","unstructured":"Agence Fran\u00e7aise de S\u00e9curit\u00e9 Sanitaire des Produits de Sant\u00e9 AFSSaPS. Rappel des sp\u00e9cialit\u00e9s \u00e0 base de benfluorex. http:\/\/www.afssaps.fr\/Infos-de-securite\/Retraits-de-lots-et-de-produits\/Rappel-des-specialites-a-base-de-benfluorex date of access 23 2 2011"},{"key":"1067_CR29","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/archinte.147.9.1577","volume":"147","author":"PF Renault","year":"1987","unstructured":"Renault PF, Hoofnagle JH, Mullen KD, Paters M, Jones DB, Rustgi V, Jones EA (1987) Psychiatric complications of long-term interferon alpha therapy. Arch Intern Med 147:1577\u20131580","journal-title":"Arch Intern Med"},{"key":"1067_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0168-8278(05)80402-7","volume":"21","author":"HL Janssen","year":"1994","unstructured":"Janssen HL, Brouwer JT, Van der Mast RC, Schalm SW (1994) Suicide associated with alpha interferon therapy for chronic viral hepatitis. J Hepatol 21:241\u2013243","journal-title":"J Hepatol"},{"key":"1067_CR31","first-page":"12","volume":"1","author":"Medicines and Healthcare Products Regulatory Agency (MHRA)","year":"2007","unstructured":"Medicines and Healthcare Products Regulatory Agency (MHRA) (2007) Varenicline: possible effects on driving; psychioatric illness. Drug Safety 1:12","journal-title":"Drug Safety"},{"issue":"suppl 1","key":"1067_CR32","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.yebeh.2003.11.008","volume":"5","author":"P Ortinski","year":"2004","unstructured":"Ortinski P, Meador KJ (2004) Cognitive side effects of antiepileptic drugs. Epilepsy Behav 5(suppl 1):S60\u2013S65","journal-title":"Epilepsy Behav"},{"key":"1067_CR33","doi-asserted-by":"crossref","first-page":"714","DOI":"10.7326\/0003-4819-143-10-200511150-00008","volume":"143","author":"DB Clifford","year":"2005","unstructured":"Clifford DB, Evans S, Yang Y, Acosta EP, Goodkin K, Simpson D, Dorfman D, Ribaudo H, Gulick RM (2005) Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals. Ann Intern Med 143:714\u2013721","journal-title":"Ann Intern Med"},{"key":"1067_CR34","first-page":"5","volume":"16","author":"C Medawar","year":"2003","unstructured":"Medawar C, Herxheimer A (2003) A comparison of adverse drug reaction reports from professionals and users, relating to the risk of dependence and suicidal behaviour with paroxetine. Int J Risk Saf Med 16:5\u201319, 2004","journal-title":"Int J Risk Saf Med"},{"key":"1067_CR35","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1520\/JFS2002173","volume":"48","author":"GB Leong","year":"2003","unstructured":"Leong GB, Silva JA (2003) Neuroleptic-induced akathisia and violence: a review. J Forensic Sci 48:1879","journal-title":"J Forensic Sci"},{"key":"1067_CR36","doi-asserted-by":"crossref","first-page":"e15337","DOI":"10.1371\/journal.pone.0015337","volume":"5","author":"TJ Moore","year":"2010","unstructured":"Moore TJ, Glenmullen J, Furberg CD (2010) Prescribed drugs associated with reports of violence towards others. PLoS Med 5:e15337","journal-title":"PLoS Med"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1067-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-011-1067-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1067-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T08:48:52Z","timestamp":1558687732000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-011-1067-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,8]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1007\/s00228-011-1067-7","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,8]]}}}